Literature DB >> 17944884

Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients.

Dong Dae Seo1, Han Chu Lee, Ha Jung Kim, Hyun Ju Min, Kang Mo Kim, Young Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh, Eunsil Yu, Sun Young Chun.   

Abstract

BACKGROUND AND AIM: Recent studies have disclosed alterations in neural and/or epithelial cadherin (E-cadherin) expression in several epithelial tumors. However, the clinical relevance of these phenomena in hepatocellular carcinoma (HCC) remains to be established. In this study, we investigated the expression patterns of neural and epithelial cadherins and their clinical implications in HCC.
METHODS: Immunohistochemical staining for neural and epithelial cadherins was performed on tumor and adjacent non-tumor tissue sections of 52 HCC patients subjected to curative surgical resection. Clinical, radiological, and histopathological characteristics were analyzed, relative to the degree of neural and E-cadherin expression.
RESULTS: The neural cadherin (N-cadherin) expression was upregulated in 67% of HCC tissues, compared to adjacent non-tumoral liver tissues. Patients expressing high levels of N-cadherin experienced more frequent tumor recurrences within 2 years (50% vs 12.5%; P = 0.01) after surgical resection. Consequently, the cumulative overall survival rate tended to be lower in patients overexpressing N-cadherin (P = 0.08). The N-cadherin overexpression was the only independent predictive factor for postoperative recurrence within 2 years in both univariate and multivariate analyses (odds ratio: 8.5; 95% confidence interval: 1.625-44.46; P = 0.011). No correlation was evident between E-cadherin expression patterns and clinicopathological parameters.
CONCLUSION: The overexpression of N-cadherin is significantly related to postoperative recurrence within 2 years after surgical resection in HCC. Therefore, immunohistochemical staining for N-cadherin may be effectively applied as a predictive marker for early postoperative recurrence in HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17944884     DOI: 10.1111/j.1440-1746.2007.05182.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  High N-Cadherin Protein Expression in Ovarian Cancer Predicts Poor Survival and Triggers Cell Invasion.

Authors:  Mourad Assidi
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

2.  MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Shao-Jun Zhou; Fu-Yao Liu; An-Hong Zhang; Hui-Fang Liang; Ye Wang; Rong Ma; Yuan-Hui Jiang; Nian-Feng Sun
Journal:  Br J Cancer       Date:  2017-06-06       Impact factor: 7.640

Review 3.  Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis.

Authors:  Yong Luo; Ting Yu; Qiongwen Zhang; Qingyu Fu; Yuzhu Hu; Mengmeng Xiang; Haoning Peng; Tianying Zheng; Li Lu; Huashan Shi
Journal:  Eur J Clin Invest       Date:  2018-02-25       Impact factor: 4.686

Review 4.  Role of Cadherins in Cancer-A Review.

Authors:  Ilona Kaszak; Olga Witkowska-Piłaszewicz; Zuzanna Niewiadomska; Bożena Dworecka-Kaszak; Felix Ngosa Toka; Piotr Jurka
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

5.  Knockdown of RSPH14 inhibits proliferation, migration, and invasion and promotes apoptosis of hepatocellular carcinoma via RelA.

Authors:  Dawei Yuan; Rulan Ma; Tuanhe Sun; Kun Zhu; Chengxue Dang; Haixia Ye; Kang Li
Journal:  Cancer Cell Int       Date:  2022-03-19       Impact factor: 5.722

6.  Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.

Authors:  Tiemo Sven Gerber; Dirk Andreas Ridder; Mario Schindeldecker; Arndt Weinmann; Diane Duret; Kai Breuhahn; Peter R Galle; Peter Schirmacher; Wilfried Roth; Hauke Lang; Beate Katharina Straub
Journal:  Cells       Date:  2022-08-12       Impact factor: 7.666

7.  Evaluation of eligibility criteria in living donor liver transplantation for hepatocellular carcinoma by α-SMA-positive cancer-associated fibroblasts.

Authors:  Hiroyuki Takamura; Shinichi Nakanuma; Hironori Hayashi; Hidehiro Tajima; Kaheita Kakinoki; Seisyo Sakai; Isamu Makino; Hisatoshi Nakagawara; Tomoharu Miyashita; Koichi Okamoto; Keishi Nakamura; Katunobu Oyama; Masashi Inokuchi; Itasu Ninomiya; Hirohisa Kitagawa; Sachio Fushida; Takashi Fujimura; Ichiro Ohnishi; Masato Kayahara; Takashi Tani; Kuniaki Arai; Taro Yamashita; Tatsuya Yamashita; Hoshiko Kitamura; Hiroko Ikeda; Shuichi Kaneko; Yasuni Nakanuma; Osamu Matsui; Tetsuo Ohta
Journal:  Oncol Rep       Date:  2013-07-16       Impact factor: 3.906

8.  miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells.

Authors:  Jing-Song Chen; Li-Li Liang; Hong-Xu Xu; Fan Chen; Shun-Li Shen; Wei Chen; Lian-Zhou Chen; Qiao Su; Long-Juan Zhang; Jiong Bi; Wen-Tao Zeng; Wen Li; Ning Ma; Xiao-Hui Huang
Journal:  Oncotarget       Date:  2016-06-17

Review 9.  N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer.

Authors:  Krzysztof Marek Mrozik; Orest William Blaschuk; Chee Man Cheong; Andrew Christopher William Zannettino; Kate Vandyke
Journal:  BMC Cancer       Date:  2018-10-01       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.